Your shopping cart is currently empty

TMX-4100, a selective phosphodiesterase 6D (PDE6D) degrader, demonstrates high degradation preference (DC50 <200 nM) in MOLT4, Jurkat, and MM.1S cells. This compound can be used for multiple myeloma research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $100 | - | In Stock | |
| 5 mg | $247 | - | In Stock | |
| 10 mg | $396 | - | In Stock | |
| 25 mg | $728 | - | In Stock | |
| 50 mg | $987 | - | In Stock | |
| 100 mg | $1,390 | - | In Stock | |
| 200 mg | $1,870 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $272 | - | In Stock |
| Description | TMX-4100, a selective phosphodiesterase 6D (PDE6D) degrader, demonstrates high degradation preference (DC50 <200 nM) in MOLT4, Jurkat, and MM.1S cells. This compound can be used for multiple myeloma research. |
| In vitro | Methods: MOLT4, Jurkat, and MM.1S cells were treated with TMX-4100 (40nM, 200nM, 1μM), and the expression of target proteins was detected by Western blotting. Results: TMX-4100 maintained its high degradation preference for PDE6D in MOLT4, Jurkat, and MM.1S cells, with DC50 values less than 200 nM after 4 hours of treatment at doses up to 1 μM. [1] |
| Synonyms | TMX4100 |
| Molecular Weight | 262.29 |
| Formula | C11H10N4O2S |
| Cas No. | 2367619-63-2 |
| Smiles | O=C1NC(=O)C(N2N=NC(=C2)C3=CSC=C3)CC1 |
| Relative Density. | 1.65 g/cm3 (Predicted) |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (305.01 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 1 mg/mL (3.81 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.